2187-3159 Screening compound: 4-chloro-N-{2-phenylimidazo[1,2-a]pyrimidin-3-yl}benzamide

2187-3159 Screening compound: 4-chloro-N-{2-phenylimidazo[1,2-a]pyrimidin-3-yl}benzamide
2187-3159 Screening compound: 4-chloro-N-{2-phenylimidazo[1,2-a]pyrimidin-3-yl}benzamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2187-3159
4-chloro-N-{2-phenylimidazo[1,2-a]pyrimidin-3-yl}benzamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2187-3159

Molecular Formula

C19H13ClN4O (C19 H13 ClN4 O)

Compound Name

4-chloro-N-{2-phenylimidazo[1,2-a]pyrimidin-3-yl}benzamide

IUPAC name

4-chloro-N-{2-phenylimidazo[12-a]pyrimidin-3-yl}benzamide

SMILES

O=C(c(cc1)ccc1Cl)Nc1c(-c2ccccc2)nc2ncccn12

InChI

InChI=1S/C19H13ClN4O/c20-15-9-7-14(8-10-15)18(25)23-17-16(13-5-2-1-3-6-13)22-19-21-11-4-12-24(17)19/h1-12H,(H,23,25)

InChI Key

XZNYDFZVRMSHDY-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01072113

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

348.79

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

5

Partition Coefficient, logP

3.258

Distribution Coefficient, logD

3.215

Water Solubility, LogSw

-3.86

Polar Surface Area

42.334

Acid Dissociation Constant (pKa)

8.39

Base Dissociation Constant (pKb)

3.85

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

0.00

2187-3159 in Drug Discovery

Included in Screening Libraries

Anti-Aging Library (44940 compounds)

C-Met Library (15277 compounds)

Protein-Protein Interaction Library (218420 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Type II Kinase Inhibitors Library (6956 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Metabolic
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Digestive system
  • Hemic and lymphatic
  • Endocrine
Mechanism of action:
  • Epigenetic
  • Receptor's ligands
  • PPI modulators
Targets:
  • Kinases
  • Kinases

References: we are preparing a list of scientific research reports with 2187-3159 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2187-3159?
Check Price and Availability of 2187-3159, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2187-3159 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2187-3159
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2187-3159
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2187-3159 available by request